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refl exes noted during the examination. Other 
physical examinations were within normal limits.
Laboratory examination revealed hemoglobin 
of 10.2 gram%; haematocrit of 31%; white blood 
count (WBC) of 10,200 u/L, and platelet count of 
314,000 u/L. The blood urea was 27 mg/dL and 
creatinine was 0.4 mg/dL. The electrolytes and 
liver transaminases were within normal limits. 
ANA was positive and anti-ds-DNA was 360.79. 
The erythrocyte sedimentation rate (ESR) was 
110 mm/h. Her activated partial thromboplastin 
time (aPTT) was 35.4 sec (control 33.5 sec) and 
prothrombin time (PT) 14.1 sec (control 11.6 
sec), which were normal. Radiography of the 
chest, pelvis, and lumbo-sacral were revealed no 
abnormalities. Her electrocardiography (ECG) was 
also within normal limits. 
Figure 1 : Pelvic radiography showed no abnormality 
on both femoral heads
The working diagnoses were suspected fracture 
of the right femoral head caused by suspected 
avascular necrosis, SLE, anemia, low intake, 
pressure ulcer, and immobilization. Then, she was 
given intravenous normal saline and Triofusin 
E 1000 per 24 hours, 1700 kcal diet per day, 
methylprednisolone tablets 8 mg bid, folic acid tablet 
qd, vitamin D3 tid, omeprazole 40 mg injection qd, 
tramadol 100 mg injection bid, heparine UFH 5000 
units subcutaneously bid, ceftriaxone 2 g injection 
qd, and metronidazole 500 mg infusion tid. The 
patient was planned for pelvic magnetic resonance 
imaging (MRI) and consulted to the Department 
of Orthopedic and Traumatology. On fourth day of 
hospitalization, patient and her family decided to go 
home due to fi nancial problems.
Avascular necrosis (also known as osteonecrosis, 
aseptic necrosis, or ischemic necrosis) represents 
collection of pathologic conditions from various 
etiologies causing impairment of blood supply to 
particular bone resulting in bone cellular death. 
Avascular necrosis remains a signifi cant cause 
of morbidity in patients with systemic lupus 
erythematosus (SLE).1 It often involves multiple 
joints in SLE, in which the femoral head is involved 
in most of these patients. Corticosteroids use is 
known as a major risk factor in the development 
of this complication.2-3 We report this case due to 
its quite common occurrence in SLE patients. The 
early recognition of avascular necrosis is essential 
to prevent morbidity.
CASE REPORT
A 24 year-old female patient presented to 
Emergency Department of Cipto Mangunkusumo 
General Hospital with chief complaint of pain in 
right hip two weeks prior to admission. She was 
diffi cult to move her right thigh and walk due to 
the severity of the pain. The pain was aggravated 
with movement and relieved by rest; thus, she had 
limitation of daily activities. There was no history 
of trauma or thrombotic episodes. She did not 
smoke cigarette and drink alcohol. She was not 
married. There was no family history of similar 
illness in her family. 
The patient was diagnosed with SLE two 
months prior to admission. Her chief complaint 
was dark rashes all over her extremities. She was 
given methylprednisolone 32 mg/day, omeprazole 
20 mg bid, folic acid qd, and vitamin D3 tid. Her 
rashes were improved with the medication, but she 
did not regularly visit the Allergy and Immunology 
Clinic in Cipto Mangunkusumo General Hospital. 
The physical examinaton revealed moderately 
ill-looking. Her body weight was 45 kg and her 
height was 152 cm with body mass index (BMI) of 
18.6 kg/m2. Her blood pressure was 110/70 mmHg, 
without tachycardia and tachypnea. Her body 
temperature was 37ºC. She had no malar rash or 
stomatitis, but she had hyper-pigmented macula all 
over her extremities and an ulcer in sacral region 3 
cm in diameter with clean base and no pus. There 
was no limb length discrepancy. She was diffi cult to 
move her right leg out and unable to raise that. Her 
physiological refl exes were intact. No pathological 
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Four days after the discharge, patient went for pelvic MRI. 
The test revealed collapse of the right femoral head which 
suggested avascular necrosis of the right femoral head. She 
was then lost to follow-up and had never visited the hospital 
ever since. 
Figure 2 Patient’s MRI showed collapse of the right femoral head 
(yellow arrow)
DISCUSSION
Systemic lupus erythematosus is a multisystem, autoimmune 
disease of unknown etiology. It is characterized by immune 
dysregulation that results in the production of autoantibodies, 
generation of circulating immune complexes, and activation 
of the complement system. Pathogenesis of the disease is 
apparently multifactorial with genetics, environmental, 
hormonal, and possibly viral infl uences playing a role.4
Avascular necrosis (also known as osteonecrosis, aseptic 
necrosis, or ischemic necrosis) represents conditions that 
result in impairment of blood supply to particular bone 
resulting in bone cellular death. Avascular necrosis can 
lead to architectural collapse of the subchondral bone, joint 
incongruency, and degenerative arthritis. A defi nite association 
between avascular necrosis and SLE was fi rst documented in 
1960 by Dubois and Cozen. Avascular necrosis has continued 
to be a signifi cant cause of morbidity in patients with SLE.1 
The incidence of avascular necrosis in SLE patients is 
4-16% and often involves multiple joints. The femoral head 
is involved in 80% of these patients. Corticosteroids use is a 
major risk factor in the development of this complication.1,5 A 
researcher, named Zizic concluded on the rarity of avascular 
necrosis in other steroid-dependent populations, such as 
asthma, dermatological disorder, and infl ammatory bowel 
disease, when compared to SLE.5-7 This fi nding suggests that 
additional factors specifi c to SLE itself may be responsible 
for avascular necrosis. Other features which have been 
associated with development of avascular necrosis in SLE 
include arthritis, central nervous system disease, vasculitis, 
hematologic abnormalities, Raynaud’s phenomenon, and 
antiphospholipid antibodies.2-3,5 
The pathogenesis of avascular necrosis in SLE is 
multifactorial. Some factors that may contribute are blood 
fl ow to the bone, vasculitis, and corticosteroid itself. The 
femoral head derives its blood supply from three sources: 
intraosseus cervical vessels, retinacular vessels, and the artery 
of the ligamentum teres. There are only few anastomoses to 
the femoral head. Therefore, any disruption to the blood fl ow 
of one artery above cannot be compensated by the collateral 
vasculature.2,8
It is believed that vasculitis and increased tendency to 
thrombosis as components of lupus syndrome contribute to 
avascular necrosis in SLE.5 Vasculitis is characterized by 
infl ammation of the vessel wall and intravascular activation of 
polymorphonuclear (PMN) leukocyte and release of reactive 
oxygen species. These events may stimulate aggregation 
of PMN resulting in intravascular thrombus.2 Mont et al 
found a high incidence of thrombophlebitis and vasculitis 
in patients with avascular necrosis. This suggests that the 
pathophysiological mechanisms of thrombotic and endothelial 
damage are involved in the development of avascular 
necrosis.9,10 From history taking, patient mentioned no history 
of any thrombotic events, more over from blood examination 
revealed normal hemostatic examination. 
The mechanism of steroid induced avascular necrosis is still 
not fully understood. Corticosteroids use at least 30 mg/day is 
a major risk factor in the development of this complication. 
McFarland and Frost suggested that corticosteroids may 
suppress osteoblastic function of the bone; and therefore 
impairs the host response to micro-fractures. Corticosteroids 
also exert some effect to fat metabolism, storage, and 
asymptomatic systemic fat emboli. Two hypotheses have 
been proposed in an attempt to explain the mechanism by 
which changes in fat metabolism after steroid administration 
can lead to avascular necrosis. The fi rst suggests that altered 
fat metabolism causes an increase in the size of intraosseous 
adipocytes, leading to increased intraosseous pressure which 
compromises perfusion (through activation of the coagulation 
pathway) and results in ischemia. The second proposed 
mechanism is that altered fat metabolism results in increased 
serum lipid levels with subsequent occlusion of subchondral 
vessels by fat emboli. Animal studies have proposed that 
increased levels of serum lipids leads to lipid deposition in 
the femoral head, causing femoral hypertension and ischemia. 
Fisher and Bickel concluded that systemic fat emboli caused 
a mechanical vascular obstruction on avascular necrosis.1-2,5 
Studies investigating avascular necrosis and steroid 
treatment yielded confl icting results concerning cumulative 
steroid dose, maximum daily steroid dose, route of 
administration, and duration. Aranow et al screened 62 SLE 
patients by MRI for avascular necrosis. Fourty three of 62 
patients took  30mg/day of prednisone and nine patients 
(19%) had evidence of avascular necrosis. Patients who had 
taken <30mg/day had no evidence of avascular necrosis. From 
another descriptive study done by Castro et al concluded that 
there was no signifi cant difference between the avascular 
necrosis and non-avascular necrosis group in relation to the 
maximum daily corticosteroid dose, the cumulative steroid 
dose, or methylprednisolone pulse therapy.5,9 The most 
possible contributing factor to avascular necrosis in this 
patient was steroid ingestion. 
The process of avascular necrosis may appear before the 
symptoms. It causes pain upon standing, walking, or moving 
the affected bone and the pain relieved when resting. Due to 
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severe pain, some people remember the exact day and hour 
when the pain begin to emerge. Sudden arrival of the pain may 
occur when there is disruption of the blood supply to the bone. 
In avascular necrosis of the femoral head, the groin pain may 
radiate down to one side of the thigh or felt in the buttocks. 
The gait was antalgic, trying to reduce all motion of the thigh. 
As the disorder progress, the more likely a hip fracture occurs. 
The pain somehow increases, the thigh joint becomes stiff and 
reduces its range of movement.4,11 This patient complained 
pain on her right hip accompanied with reduced motion at the 
hip.
Physical examination may reveal pain and limitation in 
passive range of motion of the hip, especially forced internal 
rotation. A distinct limitation of passive abduction may also be 
noted. Passive internal and external rotation of the extended 
leg (log roll test) and straight-leg raise against resistance may 
elicit pain as well.2 This patient experienced limitation in 
passive abduction, internal, and external rotation of the leg.
Diagnosis of avascular necrosis can be done trough 
radiographic imaging. Antero-posterior and frog-leg lateral 
radiographs should be obtained as part of the work-up; 
however, early-stage avascular necrosis is not visible on 
radiographs. MRI should be performed when avascular 
necrosis of the femoral head is suspected but not obvious on 
radiographs.12-13
The successful treatment of patients with avascular 
necrosis is related directly to the stage of disease at the time 
of diagnosis. Staging plays an important role in diagnosis. 
Ficat and Arlet described the fi rst staging system for avascular 
necrosis of femoral head in 1960. Hungerford and Lennox 
modifi ed this staging system when MRI became available, 
adding stage 0 to the classifi cation. Steinberg et al expanded 
this staging system, by dividing stage III lesions into femoral 
heads with or without collapse or hips with or without 
acetabular involvement. Ohzono et al incorporated the concept 
of location of the lesion with prognostic value. More recently, 
a new classifi cation has been completed by The Association 
Research Circulation Osseus (ARCO), which joins the 
Ficat and Arlet staging system, the Hungerford-Lennox 
modifi cation, Steinberg, and Ohzono staging systems.2,14-16 We 
report this patient based on Ficat and Arlet staging (table 1).
Table 1 Ficat and Arlet staging of avascular necrosis of femoral 
head14-16
Stage 0 No pain, normal radiographic finding, abnormal findings 
on MRI or bone scintigraphy
Stage I Pain, normal x-ray finding, abnormal findings on MRI or 
bone scintigraphy
Stage II Pain, cysts and/or sclerosis visible on x-ray, abnormal 
MRI or bone scintigraphy without subchondral fracture
Stage III Pain, femoral head collapse visible on x-ray, abnormal 
MRI or bone scintigraphy, crescent sign (subchondral 
collapse) and/or slip-off in contour of subchondral bone
Stage IV Pain, acetabular disease with joint space narrowing and 
arthritis visible on x-ray, abnormal MRI or bone scintig-
raphy
MRI, magnetic resonance imaging
 
MRI is representing the gold-standard of non-invasive 
diagnostic evaluation of avascular necrosis and become the 
most sensitive and specifi c means of diagnosing avascular 
necrosis. MRI has several advantages such as allows 
accurate staging by clearly depicting the size of the lesion; 
detection of asymptomatic lesions that are undetectable on 
plain radiographs, thus facilitating early treatment and better 
response; provides multi-planar imaging and excellent soft 
tissue resolution. Whole-body STIR (short tau inversion 
recovery) MRI permits the evaluation of the entire skeleton in 
a single examination that can be completed within a reasonable 
period of time.14,17
Characteristic MRI fi ndings for avascular of the hip include 
a low signal intensity band (seen on T1 and T2 images) that 
demarcates a necrotic antero-superior femoral head segment. 
The extent and location of femoral head necrosis on MRI have 
been studied as predictors of femoral head collapse. Smaller 
lesions (less than one fourth the diameter of the femoral 
head) and more medial lesions (away from primary weight-
bearing areas) predict a better outcome. The ability of MRI to 
detect the early stages of avascular necrosis may allow earlier 
intervention to ameliorate disease progression and to minimize 
more severe long-term sequelae.9,16-17 From patient’s pelvic 
radiography, there were no changes from the femoral head. 
So, it was decided to order more advance imaging modality of 
MRI. The MRI revealed collapse of the femoral head. Based 
on Ficat and Arlet staging, this patient was classifi ed under 
stage III. Sometimes in stage III, anteroposterior radiograph 
may appear normal, like in this patient, but frog-leg lateral 
view often reveals a crescent sign under the subchondral 
bone.18 Unfortunately, we did not perform the frog-leg lateral 
view in this patient.
Management of avascular necrosis consists of non-
operative and operative measures. Non-operative 
management is often used for small, asymptomatic lesions 
in which subchondral bone collapse is absent. Non-operative 
measure usually results in an unfavorable prognosis. Most 
methods of non-operative treatment have involved restricted 
weight bearing, pharmacologic agents, and various external, 
biophysical modalities such as electromagnetic stimulation, 
extracorporeal shock-wave therapy, and hyperbaric oxygen. 
Restricted weight bearing with use of a cane or crutches has 
not been shown to affect the natural history of the disease and 
is useful only in controlling symptoms. Those biophysical 
modalities only provide symptomatic control without altering 
the course of the disease. Pharmacological intervention 
includes statin to lower the lipid level. Pritchett reported that 
at a mean of 7.5 years avascular necrosis of the femoral head 
had been developed in only 1% of patients who were taking 
high doses of steroids as well as various statin drugs.2,4,15,19 
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Table 2 Recommendation of decision-making hierachy for 
the treatment of patients with avascular necrosis of the femoral 
head12,18-21
Stage Treatment
0 (asymptomatic, no 
radiographic changes)
Possible core decompression
I (no radiographic 
changes)
Core decompression, percutaneous drilling
II (pre-collapse) Core decompression, percutaneous drilling, 
bone-grafting, osteotomies
III (cresent sign) Hemiresurfacing, total tip arthroplasty
IV (joint deformity, ac-
etabular involvement)
Total tip arthroplasty
Operative treatment (see table 2 for recommendation) of 
avascular necrosis of the femoral head can be categorized 
as either prophylactic measures (to retard progression) or 
reconstruction procedures (after femoral head collapse). The 
most commonly performed prophylactic surgical treatment is 
core decompression (removal of the inner layer of bone) and 
bone-grafting (healthy bone from one part of the patient to 
be transplanted in the diseased area; at present vascularized-
grafts are used). Core decompression is usually performed in 
earlier stage of avascular necrosis. The goal is to decompress 
the femoral head and thereby reduce the intraosseous 
pressure in the femoral head, restore normal vascular fl ow, 
and subsequently reduce the hip pain. Bone-grafting may 
be effective, compared with core decompression, for larger 
lesions just before head collapse.14,15,18,20-21
There are some reconstruction procedures for avascular 
necrosis of femoral head such as total hip arthroplasty, 
osteotomy, limited femoral resurfacing arthroplasty, and 
bipolar arthroplasty. Most hips that undergo collapse 
ultimately require reconstruction. Prosthetic replacement 
offers the most predictable means of pain relief in advanced 
avascular necrosis. Total hip arthroplasty is a predictably 
effective treatment of avascular necrosis of the femoral head 
when the disease is progressed to Ficat and Arlet’s stages III 
and IV.14,15,20-21 This patient progressed into stage III based on 
Ficat and Arlet, so total hip replacement is mandatory in this 
case. 
SUMMARY
We have reported a case of avascular necrosis of the femoral 
head in female patient with systemic lupus erythematosus. 
Steroid might contribute as one factor for the development of 
avascular necrosis. According to the staging, the patient should 
be treated with total hip replacement, but after establishing the 
diagnosis the patient was loss to follow-up.
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